Larysa Vynohradnyk

EDUCATION

College / University

Taras Shevchenko National University of Kyiv

Highest Degree

Bachelor of Science

Major Subjects

Biology, Molecular Biology

Country

Ukraine

Lab Experience

Mammalian cell culturing and transfection; E. coli transformation; total protein, plasmid DNA, and total RNA extraction; restriction digestion; agarose gel electrophoresis; SDS-PAGE; western blotting; ELISA; PCR; RT-PCR; immunoprecipitation; immunofluorescence; work with in vivo models; immunohistochemistry and histological analysis.

Projects / Research

2024 – 2025: “Characterization of the interaction between WIP and amphiphisins in invasive breast cancer cells”, Institute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine, Kyiv, Ukraine
2024: Amgen Scholars Intern, “Early effects of cancer treatment on prepubertal testicular tissue: an animal model study”, Karolinska Institutet. Stockholm, Sweden
2023 – 2024: “Application of long non-coding RNAs as markers for breast cancer”, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine, Kyiv, Ukraine

Scholarships / Awards

2025 – 2026:	Stipend by the International Max Planck Research School
2024:	Amgen Foundation Research Scholarship
2021 – 2025:	Ukrainian State Scholarship for students with excellent studying achievements

SCIENTIFIC INTERESTS AND GOALS

The world of molecules inside of our body is still quite poorly understood, and I aim to contribute to unveiling its complexity. I am particularly interested in studying protein–protein interactions and signalling pathways in cancer, as understanding these mechanisms could open doors to targeted therapies and improved patient outcomes. This interest extends to structural biology, where I am fascinated by how the three-dimensional architecture of biomolecules dictates their function, interactions, and role in disease. I am also passionate about translational research that bridges the gap between molecular discoveries and therapeutic advances, and I aspire to make this the central focus of my work.